Cargando…
SMYD3 represses tumor-intrinsic interferon response in HPV-negative squamous cell carcinoma of the head and neck
Cancers often display immune escape, but the mechanisms are incompletely understood. Herein, we identify SMYD3 as a mediator of immune escape in human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC), an aggressive disease with poor response to immunotherapy with pembroliz...
Autores principales: | Nigam, Nupur, Bernard, Benjamin, Sevilla, Samantha, Kim, Sohyoung, Dar, Mohd Saleem, Tsai, Daniel, Robbins, Yvette, Burkitt, Kyunghee, Sievers, Cem, Allen, Clint T., Bennett, Richard L., Tettey, Theophilus T., Carter, Benjamin, Rinaldi, Lorenzo, Lingen, Mark W., Sater, Houssein, Edmondson, Elijah F., Moshiri, Arfa, Saeed, Abbas, Cheng, Hui, Luo, Xiaolin, Brennan, Kevin, Koparde, Vishal, Chen, Chen, Das, Sudipto, Andresson, Thorkell, Abdelmaksoud, Abdalla, Murali, Madhavi, Sakata, Seiji, Takeuchi, Kengo, Chari, Raj, Nakamura, Yusuke, Uppaluri, Ravindra, Sunwoo, John B., Van Waes, Carter, Licht, Jonathan D., Hager, Gordon L., Saloura, Vassiliki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407766/ https://www.ncbi.nlm.nih.gov/pubmed/37463106 http://dx.doi.org/10.1016/j.celrep.2023.112823 |
Ejemplares similares
-
SMYD3: a regulator of epigenetic and signaling pathways in cancer
por: Bernard, Benjamin J., et al.
Publicado: (2021) -
The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck
por: Saloura, Vassiliki, et al.
Publicado: (2018) -
Epigenetic Modifiers as Novel Therapeutic Targets and a Systematic Review of Clinical Studies Investigating Epigenetic Inhibitors in Head and Neck Cancer
por: Burkitt, Kyunghee, et al.
Publicado: (2021) -
WHSC1 monomethylates histone H1 and induces stem-cell like features in squamous cell carcinoma of the head and neck
por: Saloura, Vassiliki, et al.
Publicado: (2020) -
Clinicopathologic significance of protein lysine methyltransferases in cancer
por: Vougiouklakis, Theodore, et al.
Publicado: (2020)